Illinois Municipal Retirement Fund Has $3.02 Million Stock Position in Cencora, Inc. $COR

Illinois Municipal Retirement Fund increased its holdings in shares of Cencora, Inc. (NYSE:COR) by 27.6% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 9,631 shares of the company’s stock after purchasing an additional 2,081 shares during the period. Illinois Municipal Retirement Fund’s holdings in Cencora were worth $3,025,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of COR. Kemnay Advisory Services Inc. bought a new stake in Cencora in the fourth quarter valued at approximately $25,000. Oakworth Capital Inc. bought a new position in shares of Cencora during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC bought a new position in shares of Cencora during the 4th quarter worth approximately $27,000. Archer Investment Corp increased its holdings in shares of Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC acquired a new position in shares of Cencora during the 4th quarter worth approximately $29,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Cencora Price Performance

Shares of NYSE COR opened at $307.72 on Monday. The firm has a market cap of $59.87 billion, a P/E ratio of 23.60, a price-to-earnings-growth ratio of 1.71 and a beta of 0.58. The business’s 50 day moving average is $279.98 and its 200-day moving average is $317.52. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. During the same quarter last year, the firm earned $4.42 earnings per share. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Equities research analysts predict that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s payout ratio is presently 18.40%.

Cencora announced that its Board of Directors has authorized a stock repurchase program on Thursday, May 21st that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s leadership believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on COR. UBS Group increased their price target on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Robert W. Baird reduced their price objective on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. Evercore set a $360.00 price objective on shares of Cencora in a report on Wednesday, April 8th. Bank of America increased their price objective on shares of Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. Finally, Citigroup cut their target price on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. Eleven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $367.75.

Insider Activity

In other Cencora news, Director Lauren M. Tyler purchased 550 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The shares were acquired at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the purchase, the director owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. The trade was a 14.44% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.38% of the company’s stock.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.